Africa: Johnson & Johnson Must Halve Price of Lifesaving TB Drug Bedaquiline

[MSF] M édecins Sans Frontières (MSF) has launched a global campaign calling on pharmaceutical corporation Johnson& Johnson (J&J) to lower the price of its anti-tuberculosis medicine bedaquiline to no more than US$1 per day for people everywhere who need it, in order to allow scale-up of drug-resistant tuberculosis (DR-TB) treatment and reduce deaths.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news